Replies to post #468327 on NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

I can't see a situation, with today's advances and mindset of the FDA, where there would be a redo. IMO, no matter how you parse the data, it will show statistical significance in each category/endpoint. Regardless of the cross-over. I think everyone is past that.